1. Singh, AD, Bergman, L, Seregard, S. Uveal melanoma: epidemiologic aspects. Ophthalmol Clin N Am 2005; 18: 75–84, viii.
Google Scholar2. Shields, CL, Furuta, M, Thangappan, A, et al. Metastasis of uveal melanoma millimeter-by-millimeter in 8033 consecutive eyes. Arch Ophthalmol 2009; 127: 989–998.
Google Scholar | Crossref | Medline3. Landreville, S, Agapova, OA, Harbour, JW. Emerging insights into the molecular pathogenesis of uveal melanoma. Future Oncol 2008; 4: 629–636.
Google Scholar | Crossref | Medline4. Buzzacco, DM, Abdel-Rahman, MH, Park, S, et al. Long-term survivors with metastatic uveal melanoma. Open Ophthalmol J 2012; 6: 49–53.
Google Scholar | Crossref | Medline5. Nagakubo, D, Taira, T, Kitaura, H, et al. DJ-1, a novel oncogene which transforms mouse NIH3T3 cells in cooperation with ras. Biochem Biophys Res Commun 1997; 231: 509–513.
Google Scholar | Crossref | Medline6. Bonifati, V, Rizzu, P, van Baren, MJ, et al. Mutations in the DJ-1 gene associated with autosomal recessive early-onset parkinsonism. Science 2003; 299: 256–259.
Google Scholar | Crossref | Medline7. Repici, M, Straatman, KR, Balduccio, N, et al. Parkinson’s disease-associated mutations in DJ-1 modulate its dimerization in living cells. J Mol Med 2013; 91: 599–611.
Google Scholar | Crossref | Medline8. Taira, T, Takahashi, K, Kitagawa, R, et al. Molecular cloning of human and mouse DJ-1 genes and identification of Sp1-dependent activation of the human DJ-1 promoter. Gene 2001; 263: 285–292.
Google Scholar | Crossref | Medline9. Xu, S, Ma, D, Zhuang, R, et al. DJ-1 is upregulated in oral squamous cell carcinoma and promotes oral cancer cell proliferation and invasion. J Cancer 2016; 7: 1020–1028.
Google Scholar | Crossref | Medline10. Ismail, IA, Kang, HS, Lee, HJ, et al. DJ-1 upregulates breast cancer cell invasion by repressing KLF17 expression. Br J Cancer 2014; 110: 1298–1306.
Google Scholar | Crossref | Medline11. Fan, J, Ren, H, Jia, N, et al. DJ-1 decreases Bax expression through repressing p53 transcriptional activity. J Biol Chem 2008; 283: 4022–4030.
Google Scholar | Crossref | Medline12. Clements, CM, McNally, RS, Conti, BJ, et al. DJ-1, a cancer- and Parkinson’s disease-associated protein, stabilizes the antioxidant transcriptional master regulator Nrf2. Proc Natl Acad Sci U S A 2006; 103: 15091–15096.
Google Scholar | Crossref | Medline13. Wilson, MA . The role of cysteine oxidation in DJ-1 function and dysfunction. Antioxid Redox Signaling 2011; 15:111–122.
Google Scholar | Crossref | Medline14. Liu, H, Wang, M, Li, M, et al. Expression and role of DJ-1 in leukemia. Biochem Biophys Res Commun 2008; 375: 477–483.
Google Scholar | Crossref | Medline15. Bande, MF, Santiago, M, Blanco, MJ, et al. Serum DJ-1/PARK 7 is a potential biomarker of choroidal nevi transformation. Invest Ophthalmol Vis Sci 2012; 53: 62–67.
Google Scholar | Crossref | Medline16. Liu, S, Yang, Z, Wei, H, et al. Increased DJ-1 and its prognostic significance in hepatocellular carcinoma. Hepato-gastroenterol 2010; 57: 1247–1256.
Google Scholar | Medline17. Shadrach, KG, Rayborn, ME, Hollyfield, JG, et al. DJ-1-dependent regulation of oxidative stress in the retinal pigment epithelium (RPE). PloS One 2013; 8: e67983.
Google Scholar | Crossref | Medline18. Bitar, MS, Liu, C, Ziaei, A, et al. Decline in DJ-1 and decreased nuclear translocation of Nrf2 in Fuchs endothelial corneal dystrophy. Invest Ophthalmol Vis Sci 2012; 53: 5806–5813.
Google Scholar | Crossref | Medline19. Pardo, M, Garcia, A, Thomas, B, et al. Proteome analysis of a human uveal melanoma primary cell culture by 2-DE and MS. Proteomics 2005; 5: 4980–4993.
Google Scholar | Crossref | Medline20. Pardo, M, Garcia, A, Antrobus, R, et al. Biomarker discovery from uveal melanoma secretomes: identification of gp100 and cathepsin D in patient serum. J Proteome Res 2007; 6: 2802–2811.
Google Scholar | Crossref | Medline21. Pardo, M, Garcia, A, Thomas, B, et al. The characterization of the invasion phenotype of uveal melanoma tumour cells shows the presence of MUC18 and HMG-1 metastasis markers and leads to the identification of DJ-1 as a potential serum biomarker. Int J Cancer 2006; 119: 1014–1022.
Google Scholar | Crossref | Medline22. Chen, LL, Tian, JJ, Su, L, et al. DJ-1: a promising marker in metastatic uveal melanoma. J Cancer Res Clin Oncol 2015; 141: 315–321.
Google Scholar | Crossref | Medline23. Chattopadhyay, C, Kim, DW, Gombos, DS, et al. Uveal melanoma: from diagnosis to treatment and the science in between. Cancer 2016; 122: 2299–2312.
Google Scholar | Crossref | Medline24. Liu, C, Liu, X, Qi, J, et al. DJ-1 in ocular diseases: a review. Int J Med Sci 2018; 15: 430–435.
Google Scholar | Crossref | Medline25. Grzmil, M, Voigt, S, Thelen, P, et al. Up-regulated expression of the MAT-8 gene in prostate cancer and its siRNA-mediated inhibition of expression induces a decrease in proliferation of human prostate carcinoma cells. Int J Oncol 2004; 24: 97–105.
Google Scholar | Medline26. MacKeigan, JP, Clements, CM, Lich, JD, et al. Proteomic profiling drug-induced apoptosis in non-small cell lung carcinoma: identification of RS/DJ-1 and RhoGDIalpha. Cancer Res 2003; 63: 6928–6934.
Google Scholar | Medline27. Davidson, B, Hadar, R, Schlossberg, A, et al. Expression and clinical role of DJ-1, a negative regulator of PTEN, in ovarian carcinoma. Hum Pathol 2008; 39: 87–95.
Google Scholar | Crossref | Medline28. Wang, H, Gao, W. DJ-1 expression in cervical carcinoma and its effects on cell viability and apoptosis. Med Sci Monit 2016; 22: 2943–2949.
Google Scholar | Crossref | Medline29. Qiu, B, Wang, J, Yu, Y, et al. DJ-1 promotes development of DEN-induced hepatocellular carcinoma and proliferation of liver cancer cells. Oncotarget 2017; 8: 8499–8511.
Google Scholar | Crossref | Medline30. Lin, JP, Pan, BC, Li, B, et al. DJ-1 is activated in medulloblastoma and is associated with cell proliferation and differentiation. World J Surg Oncol 2014; 12: 373.
Google Scholar | Crossref | Medline31. Cao, J, Chen, X, Ying, M, et al. DJ-1 as a therapeutic target against cancer. Adv Exp Med Biol 2017; 1037: 203–222.
Google Scholar | Crossref | Medline32. Ziello, JE, Jovin, IS, Huang, Y. Hypoxia-inducible factor (HIF)-1 regulatory pathway and its potential for therapeutic intervention in malignancy and ischemia. Yale J Biol Med 2007; 80: 51–60.
Google Scholar | Medline33. Kim, RH, Peters, M, Jang, Y, et al. DJ-1, a novel regulator of the tumor suppressor PTEN. Cancer Cell 2005; 7: 263–273.
Google Scholar | Crossref | Medline34. Yu, H, Waddell, JN, Kuang, S, et al. Park7 expression influences myotube size and myosin expression in muscle. PloS One 2014; 9: e92030.
Google Scholar35. Kim, YC, Kitaura, H, Taira, T, et al. Oxidation of DJ-1-dependent cell transformation through direct binding of DJ-1 to PTEN. Int J Oncol 2009; 35: 1331–1341.
Google Scholar | Medline36. Zhang, GQ, He, C, Tao, L, et al. Role of DJ-1 siRNA in reverse sensitivity of breast cancer cells to chemotherapy and its possible mechanism. Int J Clin Exp Pathol 2015; 8: 6944–6951.
Google Scholar | Medline37. Raninga, PV, Di Trapani, G, Vuckovic, S, et al. Targeted knockdown of DJ-1 induces multiple myeloma cell death via KLF6 upregulation. Apoptosis 2016; 21: 1422–1437.
Google Scholar | Crossref | Medline